FDA Data Link Diabetes Drug Class to Gallbladder Disease

(MedPage Today) -- An analysis of FDA's reporting system for adverse events turned up three dozen cases of acute gallbladder disease in patients taking glucagon-like peptide-1 (GLP-1) receptor agonists for diabetes or weight loss, including three...